A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)
Clinical trial NCT04655027 · COMPLETED
Trial details
- NCT number
- NCT04655027
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-22
- Primary completion
- 2021-10-12
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.